GenAI
We've curated 83 cybersecurity statistics about GenAI to help you understand how generative AI technologies are being leveraged for both innovative solutions and new threats in 2025.
Showing 41-60 of 83 results
71% of healthcare leaders cited GenAI as the top risk.
71% of healthcare leaders cited GenAI as the top risk.
More than three-quarters of organisations (76%) report some level of unapproved Generative AI (GenAI) usage.
Unapproved GenAI usage rates are highest in technology (40%), financial services (32%), and government (38%).
In the Middle East, unauthorised GenAI is the top insider concern (31%).
78% of all organizations intend to increase their genAI spend.
In 2025, only 36% of organizations feel confident in their ability to support large-scale genAI workloads and data volumes.
78% of organizations plan to increase investment in genAI.
Just 36% of businesses have the infrastructure to support GenAI.
Fewer than half of business executives are fully satisfied with the ROI on cloud, automation, and genAI.
82% of innovation leaders are already allocating more than 6% of their IT budgets to genAI-enabled data management.
78% of businesses are investing in GenAI.
In the three months ended May 2025, users of genAI platforms increased by 50%.
LM Studio is used by 0.9% of organisations.
Ollama is used by 33% of organisations.
75% of organisations in China reported implementing GenAI.
Web traffic to GenAI sites increased by 50%, from 7 billion visits in February 2024 to 10.53 billion in January 2025.
7.2% of organisations are utilising Google Vertex AI.
In May 2025, 41% of organisations were already using at least one genAI platform.
Two-thirds (66%) of organisations have users making API calls to api.openai.com.